• 1
    Kobayashi M, Fitz L, Ryan M et al. Identification and purificaton of natural killler cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170:827 45.
  • 2
    Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787 93.
  • 3
    Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'garra A, Murphy KM. Development of Th1, CD4+ T cells through IL−12 produced by Listeria–induced macrophages. Science 1993; 260:547 9.
  • 4
    Scharton-Kersten T, Afonso LC, Wysocka M, Trinchieri G, Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental Leishmaniasis. J Immunol 1995; 154:5320 30.
  • 5
    D'anrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-gamma-production by suppressing natural killer cell stimulatory factor IL-12 synthesis in accessory cells. J Exp Med 1993; 178:1041 8.
  • 6
    D'andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G. Stimulatory and inhibitory effects of interleukin-4 (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J Exp Med 1995; 181:537 46.
  • 7
    Segal BM, Klinman M, Shevach EM. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J Immunol 1997; 158:5087 90.
  • 8
    O'hara RM, Henderson SL, Nagelin A. Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice. Ann NY Acad Sci 1996; 795:241 9.
  • 9
    Germann T, Hess H, Szeliga J, Rude E. Characterization of the adjuvant effect of IL-12 and efficacy of IL-12 inhibitors in type II collagen-induced arthritis. Ann NY Acad Sci 1996; 795:227 40.
  • 10
    Chougnet C, Wynn TA, Clerici M et al. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis 1996; 174:46 53.
  • 11
    Poyner DR. Calcitonin gene-related peptide: multiple actions, multiple receptors. Pharmacol Ther 1992; 56:23 51.
  • 12
    Umeda Y & Arisawa M. Characterization of the calcitonin gene-related peptide in mouse T lymphocytes. Neuropeptides 1989; 14:237 42.
  • 13
    McGillis JP, Humphreys S, Reid S. Characterization of functional calcitonin gene-related peptide receptors on lymphocyte membrane properties. J Immunol 1991; 147:3482 9.
  • 14
    Owan I & Ibaraki K. The role of calcitonin gene-related peptide (CGRP) on macrophages: the presence of functional receptors and effects on proliferation and differentiation into osteoclast-like cells. Bone Mineral 1994; 24:151 64.
  • 15
    Umeda Y, Takamiya M, Yoshizaki H, Arisawa M. Inhibition of mitogen-stimulated T lymphocyte proliferation by calcitonin gene-related peptide. Biochem Biophys Res Commun 1988; 154:227 35.
  • 16
    Wang X, Fiscus RR, Tang Z, Yang L, Wu J, Fan S, Mathews HL. CGRP in the serum of endotoxin-treated rats suppresses lymphoproliferation. Brain Behav Immun 1994; 8:282 92.
  • 17
    Casini A, Geppetti P, Maggi CA, Surrenti C. Effects of calcitonin gene-related peptide (CGRP), NKA and NKA (4–10) on the mitogen response of human peripheral blood mononuclear cells. Naunyn-Schmiedeberg's Arch Pharmacol 1989; 339:354 8.
  • 18
    Umeda Y. Inhibition of immune responses by calcitonin gene-related peptide. Ann NY Acad Sci 1992; 657:552 4.
  • 19
    Wang X, Fiscus RR, Yang L, Mathews HL. Suppression of the functional activity of IL-2-activated lymphocytes by CGRP. Cell Immunol 1995; 162:105 13.
  • 20
    Feng Y, Tang Y, Guo JX, Wang X. Inhibition of LPS-induced TNF-α production by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages. Life Sci 1997; 61:281 7.
  • 21
    Tang Y, Feng Y, Wang X. Calcitonin gene-related peptide potentiates LPS-induced IL-6 release from mouse peritoneal macrophages. J Neuroimmunol 1998; 84:207 12.
  • 22
    Torri H, Hosoi J, Beissert S et al. Regulation of cytokine expression in macrophages and the Langerhans' cell-like line XS52 by calcitonin gene-related peptide. J Leukoc Biol 1997; 61:216 23.
  • 23
    Nong YH, Titus RG, Ribeiro JMC, Remold HG. Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol 1989; 143:45 9.
  • 24
    Fox FE, Kubin M, Cassin M. Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12. J Invest Dermatol 1997; 108:43 8.
  • 25
    Tang Y, Han C, Fiscus RR, Wang X. Increase of calcitonin gene-related peptide (CGRP) release and mRNA levels in endotoxic rats. Shock 1997; 7: 225 9.
  • 26
    Chomczynski P & Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 1987; 162:156 9.
  • 27
    Suzumura A, Sawada M, Takayanagi T. Production of interleukin-12 and expression of its receptors by murine microglia. Brain Res 1998; 787:139 42.
  • 28
    Chijiwa T, Mishima A, Hagiwara M et al. Inhibition of forskolin-induced meurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-p-bromocinnamylamino)ethyl]-5-isoquinoleinsulfonamide (H89), of PC12 D pheochromocytoma cells . J Biol Chem 1990; 265:5267 72.
  • 29
    Vignery A, Wang F, Ganz MB. Macrophages express functional receptors for calcitonin gene-related peptide. J Cell Physiol 1991; 149:301 6.
  • 30
    Abello J, Kaiserlian D, Cuber JC, Revilard JP, Chayvialle JA. Characterization of calcitonin gene-related peptide receptors and adenylate cyclase response in the murine macrophage cell line P388D1. Neuropeptides 1991; 19:43 9.
  • 31
    Van-der-Pouw-Kraan TC, Snijders A, Boeije LC, De-Groot ER, Alewijnse AE, Leurs R, Aarden LA. Histamine inhibits the production of interleukin−12 through interaction with H2 receptors. J Clin Invest 1998; 102:1866 73.
  • 32
    Wu CY, Wang K, McDyer JF, Seder RA. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J Immunol 1998; 161:2723 30.
  • 33
    Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998; 161:2586 93.
  • 34
    Bordignon P, Mazzeo D, Lucia PD, D'ambrosio D, Lang R, Fabbri L, Selfb C, Sinigaglia F. Beta2-agonist prevents Th1 development by selective inhibition of interleukin-12. J Clin Invest 1997; 100:1513 9.
  • 35
    RieSeries C, Bock G, Klocker H, Bartsch G, Thurnher M. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med 1997; 186:1603 8.
  • 36
    Gonzalez GA & Montiminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989; 59:675 80.
  • 37
    Wang X, Jones SB, Zhou Z, Han C, Fiscus RR. Calcitonin gene-related peptide (CGRP) and neuropeptide Y (NPY) levels are elevated in plasma and decreased in vena cava during endotoxin shock in the rat. Circ Shock 1992; 36:21 30.
  • 38
    Skeen MJ, Miller MA, Shinnich TM, Ziegler HK. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines . J Immunol 1996; 156:1196 206.
  • 39
    Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251 76.